Juxtaposing Hypertension Guidelines: Are They Different? A Pragmatic Look to ESC and ESH Guidelines on (Arterial) Hypertension

Hypertension is a major public health challenge as its prevalence continues to increase despite the optimisation of therapies. According to the latest WHO/Europe report, “Action on salt and hypertension”, 36.9% of people in Europe have hypertension [1]. In 2019, more than 20% of deaths in Europe have been caused by high systolic blood pressure, and the proportion of hypertensive patients who do not achieve adequate blood pressure control was from more than 60% up to over than 80%, very heterogeneous if we look at each European country individually [2]